Cabot Corporation (NYSE:CBT) Stock Has Consensus Price Target of $89.00

Cabot Corporation (NYSE:CBT) has been assigned an average rating of “Hold” from the seven ratings firms that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and two have given a buy recommendation to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $87.80.

Several brokerages have recently commented on CBT. UBS Group lowered their target price on shares of Cabot from $92.00 to $86.00 and set a “neutral” rating for the company in a report on Monday. Truist Financial set a $100.00 price target on shares of Cabot in a report on Wednesday, August 5th. JPMorgan Chase & Co. upped their price objective on shares of Cabot from $70.00 to $78.00 and gave the stock an “underweight” rating in a research report on Friday, August 7th. Mizuho increased their price objective on shares of Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a research note on Thursday, June 25th. Finally, Wall Street Zen lowered shares of Cabot from a “buy” rating to a “hold” rating in a research note on Saturday, October 3rd.

Insiders Place Their Bets

In other Cabot news, CEO Sean Keohane sold 134,895 shares of the stock in a transaction dated Friday, August 28th. The shares were sold at an average price of $85.00, for a total transaction of $11,466,075.00. Following the completion of the transaction, the chief executive officer owned 404,134 shares in the company, valued at $34,351,390. This trade represents a 25.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders have sold a total of 229,597 shares of company stock worth $19,646,746 in the last three months. 3.08% of the stock is owned by company insiders.

Hedge Funds Weigh In On Cabot

Hedge funds have recently made changes to their positions in the stock. Bank of America Corp DE bought a new stake in Cabot during the second quarter valued at $150,772,000. Lazard Asset Management LLC grew its position in Cabot by 96.2% during the first quarter. Lazard Asset Management LLC now owns 43,219 shares of the specialty chemicals company’s stock worth $3,255,000 after buying an additional 21,194 shares in the last quarter. First Eagle Investment Management LLC increased its stake in Cabot by 52.5% in the 2nd quarter. First Eagle Investment Management LLC now owns 208,450 shares of the specialty chemicals company’s stock worth $18,931,000 after acquiring an additional 71,800 shares during the last quarter. Hsbc Holdings PLC raised its holdings in shares of Cabot by 495.9% in the 2nd quarter. Hsbc Holdings PLC now owns 18,575 shares of the specialty chemicals company’s stock valued at $1,690,000 after acquiring an additional 15,458 shares in the last quarter. Finally, State Street Corp raised its holdings in shares of Cabot by 6.8% in the 2nd quarter. State Street Corp now owns 2,165,434 shares of the specialty chemicals company’s stock valued at $196,665,000 after acquiring an additional 138,098 shares in the last quarter. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Cabot Trading Up 0.4%

NYSE:CBT opened at $75.68 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97. The firm has a 50-day moving average of $81.74 and a 200-day moving average of $82.44. The company has a market cap of $3.91 billion, a PE ratio of 21.32, a PEG ratio of 8.88 and a beta of 0.83. Cabot has a one year low of $58.33 and a one year high of $94.53.

Cabot (NYSE:CBT) last announced its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, beating the consensus estimate of $1.66 by $0.01. The business had revenue of $982.00 million for the quarter, compared to analysts’ expectations of $943.16 million. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.90 EPS. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, equities research analysts expect that Cabot will post 6.35 EPS for the current fiscal year.

About Cabot

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company develops and manufactures materials used by industrial and consumer-product manufacturers worldwide.

Cabot’s products include reinforcing carbon blacks used in tires, automotive components, and other rubber products; specialty carbon blacks used in coatings, plastics, inks, and batteries; and fumed silica used in adhesives, sealants, coatings, and personal-care applications.